Haha, not the intention. Let's all keep it professional.
Ok, so I see what your saying, but its just not a stat that I think is concerning in the broader context. My understanding of your comments is that you are worried that from Q3 to Q4 2017 rev growth with 6%, but Q3 to Q4 2018 its only 3%.
My feeling is that in cherry picking stats of that nature we're overlooking that YoY it's up 37%. Not bad. Also take for example the call they made to spend $94k on marketing in June alone. Ok, if they kept that 94k in the pocket then all of a sudden the Q4 result is 18% up (granted some downturn in rev would results from slowing marketing). That level of analysing percentage change is in the 'who cares?' basket for me. The broader context is annual growth at a pretty good rate, increases in customers, increases in ARPU (a full $1 increase is pretty damn good! I haven't seen any comments on this) and ultimately the fact that they are basically at break even depending on how they spent their money in the quarter.
It's a very positive position IMO.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report and App 4C
Haha, not the intention. Let's all keep it professional. Ok, so...
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $14.35M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.2¢ | $2.106K | 94.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 192712 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 11104 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 327598 | 0.017 |
3 | 139228 | 0.016 |
9 | 948115 | 0.015 |
3 | 445000 | 0.014 |
3 | 191615 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 345544 | 1 |
0.019 | 168070 | 4 |
0.020 | 2702 | 1 |
0.021 | 382000 | 3 |
0.022 | 18333 | 1 |
Last trade - 10.13am 25/11/2024 (20 minute delay) ? |
Featured News
RNT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online